Back to top
more

Straumann Holding AG (SAUHF)

(Delayed Data from OTC)

$796.84 USD

796.84
NA

-44.32 (-5.27%)

Updated Apr 30, 2019 02:21 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Straumann Holding AG (SAUHF) Is a Great Choice for 'Trend' Investors, Here's Why

by Zacks Equity Research

Straumann Holding AG (SAUHF) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Here's Why Momentum in Straumann Holding AG (SAUHF) Should Keep going

by Zacks Equity Research

Straumann Holding AG (SAUHF) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Straumann Holding AG (SAUHF) Upgraded to Buy: Here's Why

by Zacks Equity Research

Straumann Holding AG (SAUHF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Here's What Could Help Straumann Holding AG (SAUHF) Maintain Its Recent Price Strength

by Zacks Equity Research

Straumann Holding AG (SAUHF) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

What Makes Straumann Holding AG (SAUHF) a Good Fit for 'Trend Investing'

by Zacks Equity Research

If you are looking for stocks that are well positioned to maintain their recent uptrend, Straumann Holding AG (SAUHF) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Straumann Holding AG (SAUHF) Is a Great Choice for "Trend" Investors, Here's Why

by Zacks Equity Research

Straumann Holding AG (SAUHF) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

All You Need to Know About Straumann Holding AG (SAUHF) Rating Upgrade to Strong Buy

by Zacks Equity Research

Straumann Holding AG (SAUHF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Omnicell (OMCL) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

Omnicell (OMCL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Merit Medical (MMSI) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Sejuti Banerjea headshot

Three Things to Focus On This Earnings Season

by Sejuti Banerjea

Here are three tips to investing in this earnings season.

Debanjana Dey headshot

Dental Space Gains Momentum in 2021: 4 Stocks to Invest in

by Debanjana Dey

Dental stocks like Henry Schein (HSIC), Align Technology (ALGN), Straumann Holding (SAUHF) and DENTSPLY SIRONA (XRAY) are expected to continue their run over the next few months.

Align (ALGN) to Launch Limited-Edition Invisalign Aligner Case

by Zacks Equity Research

Align (ALGN) partners with a popular social media star to release a limited-edition case for Invisalign aligners.

BD's (BDX) Rapid COVID-19 Test for US Olympic Trial Swimmers

by Zacks Equity Research

BD (BDX) to provide rapid antigen testing for COVID-19 at the U.S. Olympic Team Trials and other competitive swimming events on behalf of USA Swimming.

HSIC vs. SAUHF: Which Stock Is the Better Value Option?

by Zacks Equity Research

HSIC vs. SAUHF: Which Stock Is the Better Value Option?

Henry Schein (HSIC) Clinches HHS Deal for COVID-19 Supplies

by Zacks Equity Research

Henry Schein (HSIC) to extend effective inventory management and extensive logistical support for PPE and COVID related products within the spectrum of U.S. health care.

Medtronic (MDT) Diabetes Arm Secures Two Approvals in Europe

by Zacks Equity Research

These two latest innovations are likely to enable Medtronic (MDT) to offer the only pump that adjusts and corrects every five minutes with an infusion set that lasts twice as long.

HSIC vs. SAUHF: Which Stock Is the Better Value Option?

by Zacks Equity Research

HSIC vs. SAUHF: Which Stock Is the Better Value Option?

Align (ALGN) Unveils New Product for Better Treatment Option

by Zacks Equity Research

Align Technology's (ALGN) latest product to aid in improving doctor performance and ensure better treatment planning.

Idexx (IDXX) Hits 52-Week High, Can the Run Continue?

by Zacks Equity Research

Idexx (IDXX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

LabCorp (LH) Looks Good: Stock Adds 9% in Session

by Zacks Equity Research

LabCorp (LH) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

Cerner's (CERN) AbleVets Buyout to Boost Federal Services

by Zacks Equity Research

Cerner (CERN) expects to close the AbleVets deal in the fourth quarter of 2019.

Here's Why You Should Add PRA Health to Your Portfolio Now

by Zacks Equity Research

PRA Health (PRAH) is gaining steadily from expansion in international markets, solid 2019 outlook and growing CRO industry.

Here's Why You Should Add Allscripts to Your Portfolio Now

by Zacks Equity Research

Allscripts' (MDRX) focus on innovation makes it a worthy investment pick.

Here's Why You Should Retain Intuitive Surgical for Now

by Zacks Equity Research

Intuitive Surgical (ISRG) continues to benefit from da Vinci surgical system, strong global foothold and solid recurring revenue base. However, margin contraction continues to raise concern.

Here's Why You Should Hold on to NextGen Healthcare for Now

by Zacks Equity Research

NextGen Healthcare (NXGN) is gaining traction from the U.S. RCM market and the growing EHR market. However, margin pressure remains a concern.